Wealthspire Advisors (New York)’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$599K Buy
2,845
+1,680
+144% +$360K ﹤0.01% 735
2026
Q1
$258K Sell
1,165
-365
-24% -$89.3K ﹤0.01% 776
2025
Q4
$388K Buy
1,530
+365
+31% +$91.7K ﹤0.01% 700
2025
Q3
$288K Sell
1,165
-406
-26% -$97.2K ﹤0.01% 687
2025
Q2
$377K Buy
1,571
+373
+31% +$86.8K ﹤0.01% 607
2025
Q1
$272K Buy
+1,198
New +$263K ﹤0.01% 667
2024
Q4
– Sell
-1,204
Closed -$292K – 837
2024
Q3
$292K Buy
+1,204
New +$282K ﹤0.01% 626
2021
Q4
– Sell
-2,834
Closed -$579K – 619
2021
Q3
$579K Buy
+2,834
New +$606K 0.01% 331

Other funds holding STE

Wealthspire Advisors (New York)'s STE Position: Q2 2026 in Review

Wealthspire Advisors (New York) increased its Steris (STE) stake by 144% in Q2 2026, buying an estimated $360K and bringing the position to 2,845 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #735.

Wealthspire Advisors (New York) first reported a position in STE in Q3 2021 and has held it in 8 quarters since. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Wealthspire Advisors (New York) held 2,845 shares of Steris worth $599K as of Q2 2026.
  • Wealthspire Advisors (New York) bought 1,680 Steris shares in Q2 2026, an estimated $360K.
  • Steris made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #735 holding.
  • Wealthspire Advisors (New York) first reported a position in Steris in Q3 2021 and has held it in 8 quarters since.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.